Commentary

Nulla eu felis ligula. Nulla porttitor sapien auctor odio lobortis sagittis. Nulla facilisi. Etiam aliquet arcu ac tempor luctus. Nunc eleifend mi faucibus tellus maximus, sed auctor turpis faucibus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis velit vel erat maximus feugiat nec vitae lacus. Nulla facilisi.

Sed quis vestibulum mauris. Fusce varius cursus est, ac auctor lorem rutrum sit amet. Suspendisse vel lacus eget libero auctor aliquam at nec sapien. Donec auctor, neque in tincidunt mollis, quam leo sagittis nisl, a tempor velit nunc at dui. Morbi malesuada sit amet ligula vel euismod. Cras porttitor orci non justo imperdiet vulputate. Morbi in nibh pretium, finibus augue rhoncus, pulvinar lectus. Nunc sollicitudin tempor volutpat.

It's nice to have  Bull market in Tech and Medical Tech to finally boost some of our positions. Some quick updates: Recent positions VIR and ATOM VIR $41 up 30% on NATURE publication today (Advised buy ranges 29-32 on April 22) This was alerted in the $30 area recently...

Things are turning up in the Medical Technology area and our TPS Portfolio right now is skewed in that area on purpose. Look for more stocks in the coming 15-60 days as I may move a little faster now, almost intermediate type swings if you will...

VIR- VIR Biotechnology  $30 area Infectious diseases are among the leading causes of death worldwide. Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. 3.3 Billion market Cap CEO former CEO of Biogen Well cashed up with over...

Last updated a few weeks ago, we are seeing strength in our remaining positions. I am covering 5 names now at about 40% portfolio weight with 60% cash. There is risk of one more market pullback perhaps, but its 50-50 now so I'm trying to...

indian xxnx horny desi indian cheating slime wife show boobs in webcam.